Digital business solutions and services provider Conduent Incorporated (Nasdaq:CNDT) announced on Thursday that the Republic of Ireland's Health Service Executive (HSE) has selected its Maven Disease Surveillance & Outbreak Management System to enhance infectious disease tracking and management.
Under a five-year contract, Maven will replace HSE's legacy system, providing more efficient disease event generation and data integration.
Maven will enable seamless coordination among medical professionals and epidemiologists, automating the process of case reporting and significantly reducing manual data entry. The system's cloud-hosted platform is designed to offer flexibility, supporting effective collaboration and rapid responses to public health threats.
This marks Maven's first deployment in the European Union, following successful implementations in the United States, United Kingdom and Australia. Conduent's system will help HSE detect and respond to infectious disease events more rapidly across Ireland.
Maven is currently used by 28 global government agencies to manage public health threats, including COVID-19, Mpox, Ebola and measles.
bioMérieux launches rapid PCR test for equine respiratory diseases
Ondine Biomedical joins CAN Health Network to advance Steriwave adoption in Canada
Seegene presrnts CURECA conceptual video at ESCMID Global 2025
GC Biopharma's BARYTHRAX receives Korean regulatory approval
bioMérieux receives CE-marking for LUMED APSS to support antimicrobial stewardship in Europe
Ondine Biomedical's Steriwave technology reduces surgical site infections by 71% in NHS deployment
AKAGERA Medicines completes first cohort in phase 1 SAD/MAD study of AKG-100
Vast Therapeutics' ALX1 drug candidate granted QIDP designation by US FDA